Evidence map›Paper›PMID 41273664›Full record

ArticleBiochemical genetics2026

The Impact of the FXR1-FUBP1 Axis on Chemotherapy Resistance in LUSC Cells.

Renji Liang, Yuehua Li, Jiayang Chen, Hao Deng

Abstract read
PubMed Publisher
In one paragraph

Article in Biochemical genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Renji LiangDepartment of Cardiocthoracic-Vascular Surgery, The First Affiliated Hospital, Hengyang Medical School, University of South China, No. 69 Chuanshan Road, Zhengxiang District, Hengyang, 421001, Hunan, China.
Yuehua LiDepartment of Oncology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China.
Jiayang ChenDepartment of Cardiocthoracic-Vascular Surgery, The First Affiliated Hospital, Hengyang Medical School, University of South China, No. 69 Chuanshan Road, Zhengxiang District, Hengyang, 421001, Hunan, China.
Hao DengDepartment of Cardiocthoracic-Vascular Surgery, The First Affiliated Hospital, Hengyang Medical School, University of South China, No. 69 Chuanshan Road, Zhengxiang District, Hengyang, 421001, Hunan, China. 18973498933@163.com.ORCID http://orcid.org/0009-0004-0334-181X

Funding

Study on the mechanism of CircACTN4 promoting the proliferation and metastasis of lung squamous cell carcinoma B202304029220
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Chemotherapy resistanceFUBP1FXR1Immune evasionLung cancer

Identifiers

PMID41273664

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.